hims hers glp 1 & expands weight loss program to include access to compounded GLP- medications Novo Nordisk Forms GLP-1 Partnership

Metabolic risk in patients with IBD While evidence remains mixed regarding the direct impact of obesity on IBD disease activity, the literature consistently demonstrates that obesity is associated with an increased risk of surgical complications, 104 particularly post-operative infections where a systematic review found an odds ratio of 1.48 compared to non-obese patients with IBD, technical challenges in the creation of an ileal pouchanal anastomosis or stoma 105 and parastomal hernia development

"The identity of glutathione S -transferase B with ligandin, a major binding protein of liver"

[PubMed] [Google Scholar] 82.Dunn SE, et al

Fukuda M, Sawa N, Hoshino J, Ohashi K, Motoaki M, Ubara Y

Maximum no-observed-effect level (NOEL) in dogs: 200 mg/kg